Skip to content
akaturk Academic measurement
Search

Article detail · 2020 · article

Changes in the Ganglion Cell Complex Thickness After Anti-VEGF Treatment for Diabetic Macular Edema

ISSN0004-2749
YÖKSİS OpenAlex Open access · diamond
Year2020
Citations3OpenAlex
Percentile%49.3
FWCI0.151.00 = world average
Scopus (SJR)Q2
WoS (JCR)Q4

Data source split

  • YÖKSİSYÖKSİS article record
  • YÖKSİS venueARQUIVOS BRASILEIROS DE OFTALMOLOGIA
  • Catalog match (ISSN)Arquivos Brasileiros de Oftalmologia
  • OpenAlexOpenAlex enrichment (abstract, citations, topics)

Abstract

OpenAlex English

PURPOSE: To assess tomographic ganglion cell complex changes in patients with diabetic macular edema treated with intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF). METHODS: We analyzed data from 35 eyes of 35 previously untreated patients in whom diabetic macular edema improved after three loading doses of anti-VEGF injection and who did not receive repeated injections. We recorded spectral domain-optical coherence tomography assessments of ganglion cell complex and central macular thickness at baseline and monthly for three months, and on the sixth and ninth month after treatment. We compared the results with those of the unaffected eyes in the same patients and with those in a control group of patients with diabetic macular edema who were untreated. RESULTS: The mean age of the patients in the treatment group was 60 ± 4.38 years. The foveal thicknesses measured using optical coherence tomography decreased significantly from baseline to the third month post-injection (p<0.05). The mean ganglion cell complex thickness was 115.08 ± 16.72 µm before the first injection and 101.05 ± 12.67 µm after the third injection (p<0.05). The mean ganglion cell complex was 110.04 ± 15.07 µm on the sixth month (p>0.05) and 113.12 ± 11.15 µm on the ninth month (p>0.05). We found a significant difference between the patients and the control group in terms of mean ganglion cell complex thickness on the second- and third-months post-injection (p<0.05). CONCLUSION: Our study showed that the ganglion cell complex thickness in patients with diabetic macular edema decreased after the anti-VEGF injections. We cannot ascertain whether the ganglion cell complex thickness decreases were due to effects of the anti-VEGF agents or to the natural disease course.

Topics

Citations

OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.

3citationsOpenAlex · cited_by_count (cache / database)

Authors

3
  1. EMİNE ÇİLOĞLU TOROS ÜNİVERSİTESİ 1
  2. FİKRET ÜNAL 2
  3. NEŞE ÇETİN DOĞAN 3